Welcome to MedsFacts the next generation reference for medication safety. With more than 70% of all Americans currently taking at least one prescription drug – and at least 50% of all Americans taking two or more medications – it’s more critical than ever that we are informed, engaged and aware of potential side effects and adverse reactions.

MedsFacts is the premiere destination for the latest prescription drug and healthcare news. MedsFacts analyzes more than 18 million FDA adverse drug reports for 20,000 different pharmaceutical products, enabling patients and providers to better understand the potential side effects of different medications, along with potentially harmful interactions. Our easy-to-use online tools help you quickly assess the benefits and potential dangers associated with different medications. These easy-to-use diagnostic tools empower you to take charge of your health!

In conjunction with our redesigned website launch, the MedsFacts team is excited to announce our newest feature: the ability to consult with expert physicians and scientific researchers about different prescription medications. Patients can ask questions about their medications, providers can post responses to patient concerns, and patients can also schedule a personal consultation with a medication expert – all from within the MedsFacts website.

Using our community forum, you can share your own experience with different medications. Did you find that the side effects for a specific drug did not seem to apply to you? Or maybe you experienced other difficulties while taking a specific medication. Share your experiences and interact with other patients who are also taking similar medications for similar health concerns.

As a registered MedsFacts user, you can privately and securely save your medication list to the cloud. Once you’ve saved your medication list, you can receive regular updates from other patients posting questions or concerns about the same medications on your watch list. You control your communication preferences so you only receive the updates that are most relevant to your health concerns.

Wondering whether it is safe to take two medications together? Confused about your medical provider’s prescriptions? Curious if others are experiencing the same side effects as you? Sign up for MedsFacts today. Joining MedsFacts is completely free and will give you access to all our easy-to-use tools, including expert physician and researcher consultations and our community forums. You’ll be able to view user comments and concerns, and interact with patients who take similar medications.

Stay informed and take control of your health: click here to join the growing MedsFacts community.

 

About this MedsFacts analysis covering adverse side effect reports of BUMETANIDE 1.5MG patients who developed METABOLIC ACIDOSIS.

MedsFacts provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking BUMETANIDE 1.5MG reported METABOLIC ACIDOSIS to the FDA. A total of 1 BUMETANIDE 1.5MG drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between BUMETANIDE 1.5MG and METABOLIC ACIDOSIS. In doing so, we compare BUMETANIDE 1.5MG with other drugs that cause METABOLIC ACIDOSIS, to help you evaluate whether or not BUMETANIDE 1.5MG causes METABOLIC ACIDOSIS. Likewise, this page shows the most highly-reported side effects of BUMETANIDE 1.5MG, so you can see if METABOLIC ACIDOSIS ranks among BUMETANIDE 1.5MG's most well-known side effects.
Summary Statistics
Reports of BUMETANIDE 1.5MG causing METABOLIC ACIDOSIS: 1
Reports of any side effect of BUMETANIDE 1.5MG : 1
Percentage of BUMETANIDE 1.5MG patients where METABOLIC ACIDOSIS is a reported side effect: 100.0000%

FDA reports of any drug causing METABOLIC ACIDOSIS : 9265
Average percentage for all medicated patients where METABOLIC ACIDOSIS is reported as a complication: 0.0581%

Physician opinion on BUMETANIDE 1.5MG as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing BUMETANIDE 1.5MG:
( 0 patients )
Drugs with high FDA adverse event association with METABOLIC ACIDOSIS:

HEPARIN SODIUM INJECTION (1279 patients)
ASPIRIN (833 patients)
ACETAMINOPHEN (760 patients)
METFORMIN HCL (645 patients)
FUROSEMIDE (442 patients)
LASIX (434 patients)
IBUPROFEN (427 patients)
LISINOPRIL (390 patients)
SEROQUEL (348 patients)
ALLOPURINOL (337 patients)
OMEPRAZOLE (326 patients)
ATENOLOL (324 patients)
AMLODIPINE (321 patients)
PREDNISONE (312 patients)
DIGOXIN (291 patients)
ZOMETA (264 patients)
NEXIUM (259 patients)
VANCOMYCIN (257 patients)
SIMVASTATIN (249 patients)
LIPITOR (241 patients)
GLUCOPHAGE (234 patients)
LORAZEPAM (233 patients)
PROPOFOL (229 patients)
POTASSIUM CHLORIDE (225 patients)
COUMADIN (220 patients)
PAXIL (214 patients)
PROTONIX (207 patients)
PARACETAMOL (200 patients)
LEVOTHYROXINE SODIUM (199 patients)
ZOFRAN (199 patients)
FOLIC ACID (198 patients)
MORPHINE (198 patients)
HYDROCHLOROTHIAZIDE (196 patients)
DEXAMETHASONE (195 patients)
PREDNISOLONE (192 patients)
FLUCONAZOLE (191 patients)
INSULIN (187 patients)
REMICADE (181 patients)
FOSAMAX (177 patients)
HEPARIN SODIUM (176 patients)
VIOXX (176 patients)
ALBUTEROL (176 patients)
TRAMADOL HCL (174 patients)
PLAVIX (167 patients)
FLUOROURACIL (166 patients)
METHOTREXATE (166 patients)
NORVASC (164 patients)
ZOCOR (164 patients)
METOPROLOL TARTRATE (163 patients)
LAMIVUDINE (160 patients)
WARFARIN SODIUM (159 patients)
VERAPAMIL (159 patients)
GLYBURIDE (158 patients)
MYCOPHENOLATE MOFETIL (158 patients)
ZOLOFT (157 patients)
DIAZEPAM (155 patients)
AMBIEN (154 patients)
AREDIA (154 patients)
METFORMIN (150 patients)
ENALAPRIL MALEATE (149 patients)
LANTUS (149 patients)
BACTRIM (148 patients)
EXJADE (148 patients)
TOPIRAMATE (146 patients)
LANSOPRAZOLE (144 patients)
PREDNISONE TAB (144 patients)
METRONIDAZOLE (137 patients)
FENTANYL (137 patients)
METOCLOPRAMIDE (137 patients)
FLUOXETINE (137 patients)
HEPARIN (137 patients)
RAMIPRIL (136 patients)
PRILOSEC (135 patients)
PREVACID (135 patients)
ATIVAN (133 patients)
METFORMIN HYDROCHLORIDE (133 patients)
FAMOTIDINE (133 patients)
CISPLATIN (132 patients)
OXYCONTIN (131 patients)
NIFEDIPINE (129 patients)
CIPROFLOXACIN (129 patients)
CITALOPRAM HYDROBROMIDE (128 patients)
LEVOFLOXACIN (128 patients)
SPIRONOLACTONE (125 patients)
SODIUM BICARBONATE (125 patients)
XANAX (123 patients)
ALPRAZOLAM (122 patients)
AMITRIPTYLINE HCL (122 patients)
LOPRESSOR (121 patients)
CYCLOSPORINE (120 patients)
OXYCODONE HCL (120 patients)
ZYPREXA (120 patients)
LEVAQUIN (119 patients)
TEMAZEPAM (119 patients)
CYCLOPHOSPHAMIDE (119 patients)
KALETRA (118 patients)
REVLIMID (118 patients)
METHYLPREDNISOLONE (116 patients)
HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% (114 patients)
DICLOFENAC SODIUM (113 patients)
PROGRAF (113 patients)
SYNTHROID (113 patients)
DIPRIVAN (112 patients)
COREG (111 patients)
MORPHINE SULFATE (111 patients)
METOPROLOL (109 patients)
KETEK (109 patients)
LAMOTRIGINE (109 patients)
AMOXICILLIN (108 patients)
CRESTOR (108 patients)
LOVENOX (108 patients)
SODIUM CHLORIDE (108 patients)
VIREAD (107 patients)
FERROUS SULFATE TAB (107 patients)
CLARITHROMYCIN (107 patients)
COMPAZINE (107 patients)
DICLOFENAC (107 patients)
ALDACTONE (106 patients)
NEURONTIN (104 patients)
CYTARABINE (104 patients)
DECADRON (104 patients)
LYRICA (103 patients)
NITROGLYCERIN (103 patients)
TOPAMAX (103 patients)
DIOVAN (102 patients)
GABAPENTIN (100 patients)
PEPCID (100 patients)
PHENYTOIN (100 patients)
VELCADE (100 patients)
PERCOCET (98 patients)
TRAZODONE HCL (95 patients)
RISPERDAL (94 patients)
NEUPOGEN (93 patients)
DEPAKOTE (93 patients)
ZANTAC (92 patients)
ARANESP (91 patients)
BYETTA (91 patients)
AMLODIPINE BESYLATE (91 patients)
CAPTOPRIL (90 patients)
OXALIPLATIN (89 patients)
PERINDOPRIL ERBUMINE (89 patients)
MULTI-VITAMINS (89 patients)
DOPAMINE HCL (87 patients)
GENTAMICIN (87 patients)
HUMULIN R (86 patients)
LORTAB (86 patients)
NEORAL (86 patients)
RITONAVIR (84 patients)
DIFLUCAN (83 patients)
MIDAZOLAM HCL (83 patients)
HYDROCORTISONE (82 patients)
EMTRICITABINE (82 patients)
CELEBREX (82 patients)
CARVEDILOL (82 patients)
ACYCLOVIR (82 patients)
TYLENOL (CAPLET) (82 patients)
PANTOPRAZOLE (81 patients)
DILTIAZEM (81 patients)
PROMETHAZINE (80 patients)
TYLENOL (80 patients)
SOLU-MEDROL (79 patients)
NAPROXEN (79 patients)
AMARYL (78 patients)
OXYGEN (78 patients)
ACETYLSALICYLIC ACID SRT (78 patients)
GLIPIZIDE (77 patients)
VITAMIN TAB (77 patients)
PROPRANOLOL (76 patients)
SEVOFLURANE (76 patients)
COZAAR (76 patients)
MAGNESIUM SULFATE (76 patients)
ONDANSETRON (75 patients)
TORSEMIDE (75 patients)
COLCHICINE (75 patients)
MIRTAZAPINE (74 patients)
REGLAN (74 patients)
ZIDOVUDINE (73 patients)
TRUVADA (72 patients)
IPRATROPIUM BROMIDE (72 patients)
TENOFOVIR (72 patients)
RANITIDINE (72 patients)
PERINDOPRIL (71 patients)
CLONAZEPAM (70 patients)
NOVOLOG (70 patients)
ZOLPIDEM (70 patients)
CAPECITABINE (69 patients)
AUGMENTIN '125' (69 patients)
TOPROL-XL (69 patients)
VALPROIC ACID (68 patients)
ACTOS (68 patients)
GLICLAZIDE (68 patients)
CLOZAPINE (68 patients)
EFFEXOR (68 patients)
CITALOPRAM (67 patients)
TEGRETOL (66 patients)
CYMBALTA (66 patients)
LEUCOVORIN CALCIUM (66 patients)
AVANDIA (65 patients)
VALPROATE SODIUM (65 patients)
AMIODARONE HCL (65 patients)
CORDARONE (64 patients)
CALCIUM (64 patients)
LEXAPRO (64 patients)
ROCEPHIN (64 patients)
CELLCEPT (64 patients)
NYSTATIN (64 patients)
ATORVASTATIN CALCIUM (64 patients)
PAROXETINE HCL (64 patients)
VOLTAREN (63 patients)
RIBAVIRIN (63 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the MedsFacts community - currently one million members and growing! MedsFacts online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent MedsFacts Activity for BUMETANIDE 1.5MG


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a question about METABOLIC ACIDOSIS and BUMETANIDE 1.5MG, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited MedsFacts. If you have a noteworthy experience as a patient taking BUMETANIDE 1.5MG, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults MedsFacts newest feature allows patients to consult - via realtime videoconferencing - experts in BUMETANIDE 1.5MG. This premium feature connects patients to experts, regardless of geography. MedsFacts experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for BUMETANIDE 1.5MG experts. If you are a healthcare provider experienced in prescribing BUMETANIDE 1.5MG, please register here.
© 2014 MedsFacts, Inc
Privacy Policy
Terms of Use